Canada Life’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-289,747
Closed -$23.3M 2545
2016
Q4
$23.3M Sell
289,747
-3,449
-1% -$274K 0.07% 288
2016
Q3
$23.4M Buy
293,196
+8,199
+3% +$662K 0.07% 286
2016
Q2
$22.2M Sell
284,997
-163,204
-36% -$11.6M 0.07% 286
2016
Q1
$24.6M Buy
448,201
+10,109
+2% +$551K 0.09% 231
2015
Q4
$27.1M Buy
438,092
+3,793
+0.9% +$239K 0.1% 214
2015
Q3
$27.3M Buy
434,299
+27,502
+7% +$1.96M 0.11% 200
2015
Q2
$29.7M Sell
406,797
-70,823
-15% -$5.12M 0.1% 226
2015
Q1
$31.2M Buy
477,620
+1,923
+0.4% +$128K 0.11% 224
2014
Q4
$30.9M Sell
475,697
-74,500
-14% -$4.8M 0.1% 218
2014
Q3
$33.1M Buy
550,197
+8,499
+2% +$555K 0.11% 199
2014
Q2
$37.4M Sell
541,698
-429
-0.1% -$27.8K 0.12% 179
2014
Q1
$35.3M Buy
542,127
+12,421
+2% +$809K 0.12% 176
2013
Q4
$32.9M Buy
529,706
+197,333
+59% +$11.4M 0.12% 184
2013
Q3
$17.8M Buy
332,373
+107,279
+48% +$5.53M 0.07% 270
2013
Q2
$10.3M Buy
+225,094
New +$9.75M 0.07% 224

Other funds holding STJ

Canada Life's STJ Position: Q1 2017 in Review

Canada Life sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 289,747 shares — an estimated $23.3M sold.

Canada Life first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $37.4M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Canada Life reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Canada Life sold 289,747 St Jude Medical shares in Q1 2017, an estimated $23.3M.
  • Canada Life first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Canada Life's St Jude Medical position peaked at $37.4M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Canada Life's 13F filing for Q1 2017, filed 1 May 2017.